Guo, C.; Zhang, Y.; Ling, T.; Zhao, C.; Li, Y.; Geng, M.; Gai, S.; Qi, W.; Luo, X.; Chen, L.;
et al. Chitosan Oligosaccharides Alleviate Colitis by Regulating Intestinal Microbiota and PPARγ/SIRT1-Mediated NF-κB Pathway. Mar. Drugs 2022, 20, 96.
https://doi.org/10.3390/md20020096
AMA Style
Guo C, Zhang Y, Ling T, Zhao C, Li Y, Geng M, Gai S, Qi W, Luo X, Chen L,
et al. Chitosan Oligosaccharides Alleviate Colitis by Regulating Intestinal Microbiota and PPARγ/SIRT1-Mediated NF-κB Pathway. Marine Drugs. 2022; 20(2):96.
https://doi.org/10.3390/md20020096
Chicago/Turabian Style
Guo, Congcong, Yue Zhang, Tao Ling, Chongjie Zhao, Yanru Li, Meng Geng, Sailun Gai, Wei Qi, Xuegang Luo, Liehuan Chen,
and et al. 2022. "Chitosan Oligosaccharides Alleviate Colitis by Regulating Intestinal Microbiota and PPARγ/SIRT1-Mediated NF-κB Pathway" Marine Drugs 20, no. 2: 96.
https://doi.org/10.3390/md20020096
APA Style
Guo, C., Zhang, Y., Ling, T., Zhao, C., Li, Y., Geng, M., Gai, S., Qi, W., Luo, X., Chen, L., Zhang, T., & Wang, N.
(2022). Chitosan Oligosaccharides Alleviate Colitis by Regulating Intestinal Microbiota and PPARγ/SIRT1-Mediated NF-κB Pathway. Marine Drugs, 20(2), 96.
https://doi.org/10.3390/md20020096
